Enrolling by invitation NCT07622849
FMT in Transplant-related Gastrointestinal Mucositis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Fecal Microbiota.
- Who it may be relevant to
- Registry conditions: Transplant-related Gastrointestinal Mucositis. Basic parameters: 15 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
FMT in Transplant-related Gastrointestinal Mucositis Treatment
Overview
With the stem cell transplant increasing, patients which effected with transplant-related gastrointestinal mucositis (TRGM) have also increased. To evaluate the safety and efficacy of FMT for TRGM, patients with TRGM were recruited.
Interventions
- Biological Fecal Microbiota
fecal microbiota transplantation
Primary outcome measures
- aGVHD [Time frame: 2 weeks, 4 weeks, 2 months, 3 months]
Eligibility criteria
Inclusion criteria
- Transplant-related gastrointestinal mucositis
Exclusion criteria
- age>65; or age<15;
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-only
Study locations
China · 1 center
- Soochow University — Suzhou
Identifiers
NCT: NCT07622849 · FMTTRGM20230001